| P50 | author | Isabelle Navarro-Teulon | Q112178177 |
| | Caroline Bascoul-Mollevi | Q112178184 |
| P2093 | author name string | André Pèlegrin | |
| | Samir Boutaleb | |
| | Jean-Pierre Pouget | |
| | Véronique Garambois | |
| | Vincent Boudousq | |
| | Pierre-Olivier Kotzki | |
| | Lore Santoro | |
| | Monique Pèlegrin | |
| P2860 | cites work | Theoretic criteria for antibody penetration into solid tumors and micrometastases. | Q51003421 |
| | Relative therapeutic efficacy of (125)I- and (131)I-labeled monoclonal antibody A33 in a human colon cancer xenograft. | Q53753255 |
| | Human carcinoembryonic antigen cDNA expressed in rat carcinoma cells can function as target antigen for tumor localization of antibodies in nude rats and as rejection antigen in syngeneic rats | Q68012134 |
| | Antigenic sites in carcinoembryonic antigen | Q69089721 |
| | Radioimmunotherapy of the GW-39 human colonic tumor xenograft with 131I-labeled murine monoclonal antibody to carcinoembryonic antigen | Q69418907 |
| | Radioimmunotherapy and fractionated radiotherapy of human colon cancer liver metastases in nude mice | Q73023188 |
| | Paradoxical effects of iodine-125 decays in parent and daughter DNA: a new target model for radiation damage | Q73667000 |
| | Cancer therapy with Auger electrons: are we almost there? | Q73910469 |
| | Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies | Q74204396 |
| | Decreased intraperitoneal disease recurrence in epithelial ovarian cancer patients receiving intraperitoneal consolidation treatment with yttrium-90-labeled murine HMFG1 without improvement in overall survival | Q79926012 |
| | In vitro toxicity of A-431 carcinoma cells with antibodies to epidermal growth factor receptor and epithelial glycoprotein-1 conjugated to radionuclides emitting low-energy electrons | Q80542025 |
| | Random-effects models for longitudinal data | Q28279619 |
| | Radioimmunotherapy of small-volume disease of metastatic colorectal cancer | Q33341317 |
| | Phase III trial of intraperitoneal therapy with yttrium-90-labeled HMFG1 murine monoclonal antibody in patients with epithelial ovarian cancer after a surgically defined complete remission | Q33370115 |
| | Effect of antigen turnover rate and expression level on antibody penetration into tumor spheroids | Q33698791 |
| | Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer | Q33994410 |
| | Biophysical aspects of Auger processes | Q34113675 |
| | Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines | Q34345829 |
| | Radioimmunotherapy for B-cell lymphoma: Y90 ibritumomab tiuxetan and I(131) tositumomab | Q34631795 |
| | Radiobiologic principles in radionuclide therapy | Q36011251 |
| | Radioimmunotherapy and colorectal cancer | Q36058561 |
| | Cancer radioimmunotherapy with alpha-emitting nuclides | Q36102652 |
| | Radiotargeting agents for cancer therapy | Q36316905 |
| | Antibody-guided radiation therapy of cancer | Q36366528 |
| | Optimization of radioimmunotherapy of solid tumors: biological impediments and their modulation. | Q36740059 |
| | Brief overview of preclinical and clinical studies in the development of intraperitoneal radioimmunotherapy for ovarian cancer. | Q36944419 |
| | Enhanced retention of the alpha-particle-emitting daughters of Actinium-225 by liposome carriers | Q36970476 |
| | Lessons from multidisciplinary translational trials on anti-angiogenic therapy of cancer | Q37109214 |
| | Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors | Q38138826 |
| | Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methods | Q38320344 |
| | Cell membrane is a more sensitive target than cytoplasm to dense ionization produced by auger electrons. | Q39955922 |
| | In vivo bioluminescence imaging to evaluate estrogenic activities of endocrine disrupters | Q40433247 |
| | A comparison between radioimmunotherapy and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats. | Q42609788 |
| | Successful Radioimmuno-therapy for Lung Metastasis of Human Colonic Cancer in Nude Mice | Q43568517 |
| | Improved xenograft targeting of tumor-specific anti-epidermal growth factor receptor variant III antibody labeled using N-succinimidyl 4-guanidinomethyl-3-iodobenzoate | Q43851121 |
| | Improved iodine radiolabels for monoclonal antibody therapy. | Q44272054 |
| | A comparison of 4 radionuclides conjugated to antibodies for single-cell kill | Q44392814 |
| | Site-specific conjugation of a radioiodinated phenethylamine derivative to a monoclonal antibody results in increased radioactivity localization in tumor | Q46184334 |
| | The effects of adjuvant experimental radioimmunotherapy and hyperthermic intraperitoneal chemotherapy on intestinal and abdominal healing after cytoreductive surgery for peritoneal carcinomatosis in the rat. | Q46422975 |
| | Uptake of radiolabeled anti-CEA antibodies in human colorectal primary tumors as a function of tumor mass | Q47566822 |
| | Therapeutic efficacy and dose-limiting toxicity of Auger-electron vs. beta emitters in radioimmunotherapy with internalizing antibodies: evaluation of 125I- vs. 131I-labeled CO17-1A in a human colorectal cancer model | Q48017730 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | monoclonal antibody | Q422248 |
| | peritoneal carcinomatosis | Q2071182 |
| P304 | page(s) | 2033-2041 | |
| P577 | publication date | 2009-11-12 | |
| P1433 | published in | The Journal of Nuclear Medicine | Q7743608 |
| P1476 | title | Noninternalizing monoclonal antibodies are suitable candidates for 125I radioimmunotherapy of small-volume peritoneal carcinomatosis | |
| P478 | volume | 50 | |